Prostate cancer incidence and mortality in selected countries of Central Europe

Klinicka Onkologie

Volumn 24, Issue 2, 2011, Pages 126-132

  Ondrusova, Martina ^a   Muzik, J ^b   Kliment, J ^c   Gulis, G ^d   Ondrus, D ^e  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b MASARYK UNIVERSITY   (Czech Republic)

^c University Hospital in Martin   (Slovakia)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e Faculty of Natural Sciences   (Slovakia)

Author keywords

Cancer; Incidence; Mortality; Prostate; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; COMPARATIVE STUDY; CONTROLLED STUDY; CZECH REPUBLIC; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; SLOVAKIA;

ADULT; AGED; AGED, 80 AND OVER; CZECH REPUBLIC; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SLOVAKIA;

EID: 79955557282     PISSN: 0862495X     EISSN: 18025307     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Boyle P, Severi G, Giles GG. The epidemiology of prostate cancer. Urol Clin North Am 2003; 30(2): 209-217.
2. Signorello LB, Adami HO. Prostate Cancer. In: Adami HO, Hunter D, Trichopoulos D (eds.) Textbook of cancer epidemiology New York: Oxford University Press 2002: 400-428.
3. Ferlay J, Shin HR, Bray F et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. Lyon, IARC 2010. Available from: http://globocan.iarc.fr.
4. Calle EE, Rodriguez C, Walker-Thurmond K et al Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348(17): 1625-1638. (Pubitemid 36459468)
5. Ondrusova M, Plesko I, Safaei-Diba Ch et al. Comprehensive analysis of incidence and mortality of malignant tumours in the Slovak Republic. National Cancer Registry of the Slovak Republic, Bratislava, NHIC 2007 Available from http://www.nor-sk.org/.
6. Dusek L, Muzik J, Kubasek M et al. Epidemiology of Malignant Tumours in the Czech Republic. Brno, Masaryk University 2005. Available from: http://www.svod.cz.
7. Curado MP, Edwards B, Shin HR et al. Cancer Incidence in Five Continents. Vol. IX IARC Scientific Publications No. 160. Lyon: IARC 2007.
8. Safaei-Diba Ch, Plesko I, Obsitnikova A et al. Cancer incidence in the Slovak Republic 2005. National Cancer Registry of the Slovak Republic. Bratislava: NHIC 2009.
9. Aareleid T. Central and Eastern Europe. In Whelan SL (ed). IARC Newsletter No. 33. Lyon: IARC 2003.
10. Baade P, Youlden DR, Krnjacki U. International epidemiology of prostate cancer: geographical distribution and secular trends Mol Nutr Food Res 2009; 53(2): 171-184.
11. Haas GP, Delongchamps N, Brawley OW et al. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol 2008; 15(1): 3866-3871.
12. Kausitz J. Use fo radioimmunoanalysis of tumor markers in diagnosis of carcinomas of the testes and prostate. Bratisl Lek Listy 1988; 89(10): 715-724.
13. Kliment J, Ondrusova M, Abrahamova J et al. Epidemiology of malignant tumors of prostate - comparison of the population of the CR and SR. Cesk Urol 2009; 13: 79-103.
14. Horner MJ, Ries LA, Krapcho M et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, NCI 2009. Available from: http://seer.cancer.gov/csr/1975- 2006/
15. Levi F, Lucchini F, Negri E et al Leveling of prostate cancer mortality in Western Europe. Prostate 2004; 60(1): 46-52. (Pubitemid 38669228)
16. Avdicova M. Report of CINDI (Countrywide integrated non-communicable disease intervention) programme feasance in Slovak Republic, 2002. Available from: www.vzbb.sk/sk/projekty/cindi-webpdf.
17. Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality Part I: international comparison. BJU Int 2002; 90(2): 162-173. (Pubitemid 34779587)
18. La Vecchia C, Bosetti C, Lucchini F et al. Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol 2010; 21(6): 1323-1360.
19. Levi F, Lucchini F, Negri E et al. Trends in mortality from major cancers in the European Union, including acceding countries, in 2004. Cancer 2004, 101(12): 2843-2850. (Pubitemid 39603193)
20. Andriole GL, Crawford ED, Grubb RL 3rd et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360(13): 1310-1319.
21. Hussain S, Gunnell D, Donovan J et al. Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004. BJU Int 2008; 101(5): 547-555. (Pubitemid 351199281)
22. World Health Organization. The World Health Report 2004 - Changing History. Geneva, WHO 2004.
23. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85(1): 60-67.